Bayer says glyphosate-cancer legal settlement should cap future liability, as number of lawsuits surges past 40,000

Monsanto Bayer x

Already reeling from an avalanche of lawsuits, German agriculture and healthcare giant Bayer AG said on [October 30] the number of cases alleging the company’s glyphosate-based herbicides cause cancer more than doubled over the past three months, to 42,700.

Three U.S. juries have ruled against Bayer in cases brought by Americans alleging Monsanto’s popular herbicide caused their cancer …. Bayer, which says there is extensive scientific research showing that glyphosate-based herbicides are safe and do not cause cancer, is appealing the rulings and is participating in mediation, ordered by U.S. District Judge Vince Chhabria.


Law firms in the U.S. have been running TV ads advising people with cancer who have used glyphosate-based herbicides to consult them. [Company CEO Werner] Baumann said Bayer was engaging constructively in the mediation with a view to finding a solution …. He said Bayer would only accept a mediation outcome that is “financially reasonable and is structured in a way that will bring the matter to a reasonable conclusion.”

Related article:  Less milkweed due to herbicide likely contributed to early monarch butterfly declines, study finds

That means Bayer wants any settlement to cover potential future claims, giving it assurances that there would be a cap on its liability.

Read full, original article: As Roundup Lawsuits Pile Up by the Thousands, Bayer Remains Defiant

Outbreak Daily Digest
Biotech Facts & Fallacies
GLP Podcasts
Infographic: Here’s where GM crops are grown around the world today

Infographic: Here’s where GM crops are grown around the world today

Do you know where biotech crops are grown in the world? This updated ISAAA infographics show where biotech crops were ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists
Send this to a friend